Zobrazeno 1 - 10
of 84
pro vyhledávání: '"D incentives"'
Publikováno v:
Globalization and Health, Vol 18, Iss 1, Pp 1-14 (2022)
Abstract “No regrets” buying – using Advance Purchase Agreements (APAs) – has characterized the response to recent pandemics such as Avian flu, Zika Virus, and now COVID-19. APAs are used to reduce demand uncertainty for product developers an
Externí odkaz:
https://doaj.org/article/d6961f4134de49ea99ee51ecfa60f1f2
Autor:
Leon Rohde, Elias Mossialos, Charlotte Beaudart, Angelika Joos, Inka Heikkinen, Silas Holland, Mickaël Hiligsmann
Publikováno v:
Journal of Global Antimicrobial Resistance, Vol 29, Iss , Pp 42-48 (2022)
ABSTRACT: Objectives: Without intervention, experts predict that antimicrobial resistance will rank among leading drivers of mortality by 2050. New drugs are desperately needed, but given the lengthy development timelines for antimicrobial research a
Externí odkaz:
https://doaj.org/article/53b0290b8f85414790f3513cb19b1579
Autor:
Gray, Elie
Publikováno v:
Revue d'économie politique, 2018 Sep 01. 128(5), 807-848.
Externí odkaz:
https://www.jstor.org/stable/26596241
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Seldüz, Hakan, İçerli, M. Yılmaz
Publikováno v:
Sosyal Araştırmalar ve Davranış Bilimleri / Social Research and Behavioral Sciences. 4(5):96-117
Externí odkaz:
https://www.ceeol.com/search/article-detail?id=704908
Using the patent term changes in assessing the evolution of patent valuation from filing to maturity
Publikováno v:
European Journal of Innovation Management, 2016, Vol. 19, Issue 4, pp. 528-546.
Externí odkaz:
http://www.emeraldinsight.com/doi/10.1108/EJIM-04-2015-0027
Autor:
Klockhoff, Anton, Larsson, Wilmer
Objectives: The Dental and Pharmaceutical Benefits Agency (TLV) is responsible for deciding which prescription pharmaceuticals should be subsidized in Sweden. Cost-effectiveness analyses are fundamental to its decision-making, but future price reduct
Externí odkaz:
http://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-194938
Autor:
Ghislandi, Simone, Kuhn, Michael
It is frequently argued that the high costs of clinical trials prior to the admission of new pharmaceuticals are stifling innovation. At the same time, regulation of the access to markets is often justified on the basis of consumers` inability to det
Externí odkaz:
http://epub.wu.ac.at/4886/1/wp219.pdf
Autor:
Kübra Filiz GÖNEN, Mustafa KISAKÜREK
Publikováno v:
Volume: 23, Issue: 4 831-844
Cumhuriyet Üniversitesi İktisadi ve İdari Bilimler Dergisi
Journal of Economics and Administrative Sciences
Cumhuriyet Üniversitesi İktisadi ve İdari Bilimler Dergisi
Journal of Economics and Administrative Sciences
One of the important factors determining the competitiveness of countries is R&D investments. Every country that aims to increase its competitiveness wants to support the R&D investments of enterprises with incentives. Thus, businesses that want to i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd897428d8a9f7d304c9f98791659722
https://dergipark.org.tr/tr/pub/cumuiibf/issue/71333/1086803
https://dergipark.org.tr/tr/pub/cumuiibf/issue/71333/1086803